US Drug Recall Register
Class II · Moderate risk Terminated Initiated Oct 10, 2019 (7 years ago)

Lyophilized Sermorelin w/ GHRP2 3 mg For injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Sterility Assurance.

What was recalled

Lyophilized Sermorelin w/ GHRP2 3 mg For injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910

Recalling firm
Innoveix Pharmaceuticals Inc
Origin
TX, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0159-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Sermorelin recalls

See all
Class II · Moderate risk Terminated

Sermorelin Acetate 1 mg/mL

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding D-0781-2022
Class II · Moderate risk Terminated

Ipamorelin Acetate/Sermorelin Acetate

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

North American Custom Laboratories, LLC dba FarmaKeio Superior Custom Compounding D-0777-2022